Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Health Econ ; 18(10): 1114-32, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18972326

RESUMO

The Technological Change in Health Care Research Network collected unique patient-level data on three procedures for treatment of heart attack patients (catheterization, coronary artery bypass grafts and percutaneous transluminal coronary angioplasty) for 17 countries over a 15-year period to examine the impact of economic and institutional factors on technology adoption. Specific institutional factors are shown to be important to the uptake of these technologies. Health-care systems characterized as public contract systems and reimbursement systems have higher adoption rates than public-integrated health-care systems. Central control of funding of investments is negatively associated with adoption rates and the impact is of the same magnitude as the overall health-care system classification. GDP per capita also has a strong role in initial adoption. The impact of income and institutional characteristics on the utilization rates of the three procedures diminishes over time.


Assuntos
Difusão de Inovações , Ciência de Laboratório Médico/economia , Ciência de Laboratório Médico/legislação & jurisprudência , Isquemia Miocárdica/terapia , Reembolso de Incentivo , Países Desenvolvidos , Humanos , Estudos de Casos Organizacionais
2.
J Rehabil Res Dev ; 33(2): 173-83, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8724172

RESUMO

Despite long development periods for neuroprosthetic devices, the numbers in clinical use or clinical trials are rising, with an estimated 3,000 systems in use today. As they gain experience with the regulatory approval process, developers are learning to conduct research to best prepare for transfer of technology to industry. The track record of the first motor prosthesis to be approved by the United States Food and Drug Administration contains important lessons for a company planning to undergo the regulatory process. Throughout the development of a neuroprosthesis, the capabilities and preferences of the customers who will use it (physicians, surgeons, therapists, and end-users) should be sought out and used in device design. When a device has reached clinical application, particular attention is needed to maximize both the population who will use it and each individual's degree of use (optimal, partial, reluctant). Identification of person-technology mismatches can help to select training strategies and other interventions that can be applied to ensure a good rehabilitation outcome.


Assuntos
Aprovação de Equipamentos/legislação & jurisprudência , Terapia por Estimulação Elétrica/instrumentação , Ciência de Laboratório Médico/legislação & jurisprudência , Próteses e Implantes , Ensaios Clínicos como Assunto , Segurança de Equipamentos , Guias como Assunto , Humanos , Estados Unidos , United States Food and Drug Administration
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA